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Highlights: 
- Gait analysis and self-reported function are moderately correlated after total hip arthroplasty; 
- Gait analysis captures post-operative improvement beyond 3 months in follow-up; 
- Gait analysis is less sensitive to detect changes in patients with high pre-operative function; 
- One year after total hip arthroplasty, lower walking speed and smaller steps are still observed; 
- Comprehensive functional outcome assessment includes both relative and absolute changes. 
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Abstract 
Background: Functional outcome assessment after total hip arthroplasty often involves subjective patient-
reported outcome measures whereas analysis of gait is more objective. The study’s aims were to compare 
subjective and objective functional outcomes after total hip arthroplasty between patients with low and high 
self-reported levels of pre-operative physical function. 
Methods: Patients undergoing total hip arthroplasty (n=36; m/f=18/18; mean age=63.9; SD=9.8yrs; 
BMI=26.3 SD=3.5) were divided into a low and high function subgroup, and prospective measures of 
WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) function score and gait were 
compared at baseline and 3 and 12 months post-operatively.  
Findings: WOMAC function scores significantly improved in both low and high function subgroups at 3 
months post-operatively whereas gait parameters only improved in patients with a low pre-operative 
function. Between 3 and 12 months post-operatively, WOMAC function scores had not significantly further 
improved whereas several gait parameters significantly improved in the low function group. WOMAC 
function scores and gait parameters were only moderately correlated (Spearman’s r = 0.33-0.51).  
Interpretation: In a cohort of patients undergoing total hip arthroplasty, pre-operative differences in mean 
WOMAC function scores and gait parameters between low and high function subgroups disappeared by 3 
months post-operatively. Gait parameters only improved significantly during the first 3 post-operative 
months in patients with a low pre-operative function, highlighting the importance of investigating relative 
changes rather than the absolute changes and the need to consider patients with high and low function 
separately. 
Keywords: gait, inertial sensor, total hip arthroplasty, outcome assessment, PROM, WOMAC. 
Word count abstract: 237 
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1. Introduction 1 
Total hip arthroplasty (THA) is one of the most frequently performed and successful reconstructive 2 
procedures in orthopedic surgery, with more than one million procedures undertaken every year worldwide 3 
[1]. Because of an ageing population and the increase in obesity, the incidence of osteoarthritis (OA) and 4 
the number of THA’s is expected to increase substantially in future decades [2]. Although the majority of 5 
THAs are provided to patients aged 65 years and older, the proportion of patients younger than 65 years is 6 
projected to increase to 50% of all arthroplasties by 2030 [3]. With a growing and more active older 7 
population, and an increasing number of younger patients undergoing THA, the functional demands 8 
expected of THA will change and assessment of outcomes will equally need to evolve [3, 4]. Assessment 9 
of outcomes after THA often involves patient-reported outcome measures (PROMs) focusing mainly on two 10 
domains: pain and function. PROMs are widely used in research and clinical settings, and they are 11 
considered easy to use, inexpensive and time efficient. One of the most commonly used PROMs is the 12 
disease-specific Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) which has 13 
been validated for use with patients undergoing THA [5, 6]. Following THA, patients who are more satisfied 14 
are also more likely to have higher total WOMAC scores with the amount of improvement depending on 15 
baseline status [7]. Furthermore, it has been demonstrated that patients with lower pre-operative self-16 
reported WOMAC function scores do not improve their final outcomes to the same magnitude as patients 17 
with higher pre-operative scores [8]. However, WOMAC scores represent subjective self-reported 18 
measures which are easily influenced by socioeconomic or psychological factors and dominated by pain 19 
[9, 10]. Moreover, as with many orthopedic PROMs, the WOMAC score suffers from a ceiling effect as it 20 
has a limited maximum value that is reached by a substantial proportion of patients who report no pain or 21 
functional limitations after THA [11-13]. A consequence of this ceiling effect is that the true extent of patients’ 22 
post-operative functional abilities cannot be determined. Therefore, it is important that research considers 23 
other methods of assessing functional outcomes after THA. Gait analysis has widely been accepted as an 24 
objective measure of physical function, allowing researchers and clinicians to better understand 25 
biomechanical alterations in the presence of hip osteoarthritis (OA) and to evaluate the functional success 26 
of THA and rehabilitation strategies [13-15]. However, the gold standard for clinical gait analysis, an 27 
optoelectronic motion capture (MOCAP) system, is time consuming and expensive, requires a specially 28 
equipped laboratory and it is limited to a specific motion capture volume, constrained by space and 29 
equipment. As an alternative to these sophisticated but clinically unfeasible MOCAP systems, ambulant 30 
accelerometers have developed into reliable tools for the assessment of basic spatiotemporal gait 31 
parameters (e.g. cadence, step length) which can discriminate healthy subjects from OA patients [14, 16] 32 
and have demonstrated responsiveness to post-operative changes [17]. More recently, inertial sensors (i.e. 33 
accelerometer combined with a gyroscope) have been validated for kinematic measurements of gait [18, 34 
19], such as joint range of motion (ROM), and could provide more detailed information on gait disturbances 35 
in hip OA patients outside the gait laboratory [20]. Given the differences in self-reported functional outcomes 36 
between patients with low and high pre-operative function, it is important to establish if these patterns of 37 
recovery are also observed with objective measures of physical function [21, 22].  38 
 39 
The primary aim of the study was to compare the longitudinal changes in physical function between hip OA 40 
patients with a low and high self-reported level of physical function, from just prior to THA until one year 41 
post arthroplasty, assessed by a subjective patient-reported outcome measure (WOMAC function score) 42 
and an objective functional measurement (inertial sensor based gait analysis). A second aim of the study 43 
was to compare the trajectories of post-operative recovery between the WOMAC function score and gait 44 
parameters. The third aim was to compare the outcomes of gait analysis one year after THA from our cohort 45 
with those of a healthy control group. We expected that patients with a low pre-operative WOMAC function 46 
score would also demonstrate worse post-operative WOMAC function scores [8], but hypothesized that 47 
these differences may not be found with objective gait parameters as they are less influenced by 48 
socioeconomic and psychological factors [9] and weak to moderate correlations between PROMs and 49 
performance-based tests have been reported in the literature [6, 10, 17, 23, 24]. We further hypothesized 50 
that WOMAC function scores and gait parameters would demonstrate distinct post-operative recovery 51 
patterns, as for WOMAC function scores a larger change in the first 3 months and a smaller change in the 52 
following 9 months was anticipated because they are more likely influenced by ceiling effects [9, 10]. Finally, 53 
we hypothesized that gait performance in patients one year after THA would still be slightly worse compared 54 
to healthy controls [25].  55 
  56 
2. Methods 57 
2.1 Study and participants 58 
The patient data used in this analysis were from a single center prospective UK cohort study comparing 59 
functional measures in patients undergoing joint replacement (the ADAPT study). A detailed description 60 
has been reported previously [26]. From this cohort, patients listed for primary THA were selected. Patients 61 
completed the WOMAC questionnaire and their gait was assessed pre-operatively (mean=24 days; SD=13 62 
days), at 3 months (mean=106 days; SD=19 days) and at 12 months (mean=385 days; SD=22 days) post-63 
operatively. Patients with missing data at any assessment time, either from the WOMAC questionnaire or 64 
from gait analysis, were excluded from this analysis. This resulted in a study population of 36 patients 65 
(m/f=18/18; mean age=63.9; SD=9.8yrs; BMI=26.3 SD=3.5). A control group of individuals (n=30; 66 
m/f=18/12; mean age=61.0years; SD=5.6; mean BMI=24.8; SD=2.8) without joint pain and without a 67 
medical history of lower extremity joint surgery was used to compare post-operative outcomes [27]. 68 
 69 
2.2 Patient-reported outcome assessment 70 
The WOMAC score is designed to provide information on a patient’s perception of pain (5 items), stiffness 71 
(2 items) and physical function (17 items). The function dimension of the total WOMAC score (i.e. WOMAC 72 
function score) was used in this analysis. The WOMAC function score contains 17-items and each item is 73 
scored on a 5-point ordered response scale. The score was transformed to a 0-100 score, with 0 74 
representing the lowest (i.e. worst) score and 100 representing the highest (i.e. best) score [23].  75 
2.3 Gait test protocol 76 
Participants were invited to walk 20 meters along a straight flat corridor at their own preferred speed [27, 77 
28]. A 3D inertial sensor (41x63x24mm; 39g; Microstrain Inertia Link) was used, containing gyroscopes 78 
(±300°/s) and accelerometers (±5g) along orthogonal axes in frontal, sagittal and transverse plane. The 79 
sensor was attached onto the skin with a neoprene strap, and positioned centrally between the posterior 80 
superior iliac spines (PSIS) overlying S1 [27]. Data analysis was performed using algorithms in 81 
Matlab2009a to detect heel strike (HS) events during gait from the raw antero-posterior (AP) acceleration 82 
signal to derive spatiotemporal gait parameters [29], including 1) walking speed (
distance covered
time
; m/s), 2) 83 
cadence (60 ∗
step count
time
; steps/min), 3) step time (s), 4) step length (
distance covered
step count
; m); 5) step time 84 
irregularity (
SD
mean
; coefficient of variance) and 6) step time asymmetry (100% * 
(abs(left step times−right step times))
(0.5∗(left step times +right times))
; 85 
%) [27]. The sensor’s inbuilt integration of the gyroscope signals provided static and dynamic orientation 86 
angles, allowing additional kinematic characterization of the pelvis during gait. The range of motion (ROM; 87 
degrees) of the pelvis in frontal plane (i.e. pelvic obliquity) was calculated [27] as it is related to impairment 88 
of hip abductor muscles in patients with hip OA [30-32] which may persist following THA [33]. 89 
2.4 Statistical analysis  90 
Pre-operative WOMAC function score was dichotomized according to median threshold to define low and 91 
high function groups. Linear mixed models (LMM) in Stata13 were used to investigate longitudinal trends 92 
of changes post-operatively in the low and high function groups with p-values <0.05 as significance 93 
threshold. Self-reported WOMAC function scores and objective gait measures are described for each 94 
measurement point with median and interquartile range (IQR), between 25th and 75th percentile, because 95 
of the non-normal distribution of the post-operative data. Comparison of both self-reported WOMAC 96 
function scores and gait measures between low and high function groups was conducted with Mann-97 
Whitney U tests. Linear mixed models with random intercept and slope (on period’s indicators) were used 98 
to assess the magnitudes of change between pre-operative and 3 months post-operative, and between 3 99 
and 12 months post-operative. These changes were normally distributed and results are reported by the 100 
mean and 95% confidence interval (CI). The magnitudes of change (i.e. slope of curve) for WOMAC 101 
function scores and gait parameters between the first 3 post-operative months and the following 9 post-102 
operative months were quantified as averaged change per month (mean; 95% confidence interval; p-value) 103 
and outcomes were compared between low and high function groups within the LMM framework. 104 
Correlations between WOMAC function scores and gait parameters were calculated with the Spearman’s 105 
correlation coefficient and interpreted as follows: <0.2: none; 0.21-0.5 weak; 0.51–0.8: moderate; >0.81: 106 
strong [34]. 107 
3. Results  108 
Pre-operatively, the median WOMAC function score was 49 (IQR=36-71). Using this median as a cut-off, 109 
two subgroups were formed: a low function group (n=18) with a pre-operative median WOMAC function 110 
score of 36 (IQR=22-41) and a high function group (n=18) with a significantly higher pre-operative median 111 
WOMAC function score of 71 (IQR=65-82) (p<0.001). In gait, significant differences were also found 112 
between the low and high function groups for the parameters speed (0.89 vs. 1.10m/s; p=0.006), step length 113 
(0.50 vs. 0.60m; p=0.003) and ROM pelvic obliquity (4.7 vs. 6.0°; p=0.015) (table 1). In addition, significant 114 
but weak to moderate correlations were found between the pre-operative WOMAC function scores and gait 115 
parameters speed (Spearman’s r=0.51; p=0.002), step length (Spearman’s r=0.47; p=0.004) and ROM 116 
(Spearman’s r=0.43; p=0.010) (table 2). 117 
At 3 months post-operatively, WOMAC function scores had significantly improved for the total patient group 118 
(median=92; IQR=81-96; p<0.001), for the low function group (median=91; IQR=79-96; p<0.001) and high 119 
function group (median=91; IQR=84-99; p<0.001); (table 1; figure 1). Furthermore, 18 of 36 patients (50%) 120 
reached near-maximum (≥90) WOMAC function scores at 3 months post-operatively (figure 1). No 121 
significant difference in WOMAC function score was observed between the low function group and the high 122 
function group at 3 months post-operatively. The magnitude of change for WOMAC function scores during 123 
the first 3 post-operative months was significantly higher for patients from the low function group compared 124 
to patients from the high function group (averaged change per month = 13.31 vs. 3.59 points respectively; 125 
p<0.001; table 3). Gait parameters in the total patient group had also improved significantly 3 months after 126 
THA, except for step time irregularity and step time asymmetry (table 1). Sub group analysis demonstrated 127 
that the gait parameters only significantly improved in patients from the low function group and comparing 128 
the magnitudes of change (i.e. averaged change per month) during the first 3 post-operative months 129 
between the low and high function group demonstrated significant differences for the gait parameters: 130 
speed (0.060 vs. 0.011m/s resp.; p=0.007), cadence (2.64 vs. 0.35steps/min resp.; p=0.03), step time (-131 
0.019 vs. -0.002s resp. p=0.039), step length (0.023 vs. 0.04m resp.; p=0.009) and ROM (0.43 vs. 0.18° 132 
resp.; p=0.008) (figure 1, table 3). At 3 months post-operatively, patients from the low function group 133 
reached a level of walking ability comparable to patients from the high function group as median values of 134 
gait parameters were not significantly different anymore. No significant correlation for any of the gait 135 
parameters with WOMAC function score was found at 3 months post-operatively (table 2).  136 
At 12 months post-operatively, WOMAC function scores were not significantly different to WOMAC function 137 
scores measured at 3 months post-operatively in the total group, nor in the low and high function groups 138 
(table 1). In addition, 23 of 36  patients (64%) reached near-maximum (≥90) WOMAC function scores and 139 
10 of 36 patients (28%) reported the maximum WOMAC function score of 100 at 12 months post-140 
operatively. Between 3 and 12 months post-operatively, speed and step length significantly improved in the 141 
total patient group (table 1; figure 1). Separate subgroup analysis demonstrated that the observed 142 
improvement was only found in patients with a low pre-operative self-reported function. However, no 143 
differences were found for gait parameters at 3 and at 12 months post-operatively between the high and 144 
low function groups (table 1) and the averaged change per month between 3 and 12 months post-145 
operatively showed no significant differences between the low and high function groups (table 2). At 12 146 
months post-operatively, weak correlations were found between the WOMAC function score and the gait 147 
parameters speed (Spearman’s r=0.45; p=0.005), cadence (Spearman’s r=0.37; p=0.027), step time 148 
(Spearman’s r=0.37; p=0.027), ROM (Spearman’s r=0.51; p=0.002), step time irregularity (Spearman’s r=-149 
0.39; p=0.018) and step time asymmetry (Spearman’s r=-0.33; p=0.047). At 12 months post-operatively, 150 
the THA cohort approached the level of the control group comparing gait parameters, except for speed 151 
(1.20 vs. 1.29m/s; p=0.036) and step length (0.64 vs. 0.68m; p=0.004) (table 1). 152 
153 
154 
155 
156 
157 
158 
159 
160 
Figure 1, A-X: Individual (grey) and mean (black) trajectories for measures of WOMAC function score (A=total group, B=high function 161 
group, C=low function group), walking speed (D=total group, E=high function group, F=low function group), cadence (G=total group, 162 
H=high function group, I=low function group), ROM (J=total group, K=high function group, L=low function group), step time (M=total 163 
group, N=high function group, O=low function group), step length (P=total group, Q=high function group, R=low function group), step 164 
irregularity (S=total group, T=high function group, U=low function group) and step asymmetry (V=total group, W=high function group, 165 
X=low function group) during longitudinal follow-up. 166 
Outcome parameters Pre-operative 
Low vs 
High 
3 months 
Low vs 
High 
12 months 
Low vs. 
High 
Control group n=30 
    Median IQR p-value Median IQR p-value p-value Median IQR p-value p-value Median IQR p-value 
WOMAC Total 48.5 35.5-71.3   91.2 81-95.6 <0.001   95.6 83.8-100 0.44        
funtion 
Low 
function 
35.5 22.1-41.1 
  
90.9 79.4-95.6 <0.001 
  
94.1 83.8-98.5 0.89 
  
     
      
 (0-100) 
High 
function 
71.3 64.7-82.4 <0.001 91.2 83.8-98.5 <0.001 0.53 96.3 85.9-100 0.24 0.44       
Speed Total 0.97 0.81-1.12   1.12 0.96-1.30 <0.001   1.20 1.08-1.33 <0.001   1.29 1.14-1.41 0.036 
 (m/s) 
Low 
function 
0.89 0.71-0.97   1.10 0.92-1.30 <0.001   1.20 1.09-1.33 0.001        
  
High 
function 
1.10 0.97-1.24 0.006 1.16 0.98-1.36 0.28 0.45 1.23 1.07-1.34 0.055 0.69       
Cadence Total 106.0 98.4-113.9   110.5 102.3-117.3 0.008   112.7 107.3-119.3 0.056   111.6 105.4-116.3 0.54 
 (steps/min) 
Low 
function 
103.8 92.0-116.3   113.7 100.8-117.7 0.007   114.4 109.8-122.5 0.069        
  
High 
function 
108.0 99.6-111.4 0.27 110.2 106.8-115.2 0.41 0.57 110.6 102.7-116.7 0.42 0.20       
Step time Total 0.57 0.53-0.61   0.54 0.51-0.59 0.020   0.53 0.50-0.56 0.11   0.54 0.52-0.57 0.66 
 (s) 
Low 
function 
0.58 0.52-0.65   0.53 0.51-0.60 0.020   0.52 0.49-0.55 0.20        
  
High 
function 
0.56 0.54-0.60 0.27 0.55 0.52-0.56 0.48 0.57 0.54 0.51-0.59 0.35 0.20       
Step length Total 0.54 0.48-0.62   0.60 0.53-0.68 <0.001   0.64 0.57-0.70 <0.001   0.68 .63-0.75 0.004 
 (m) 
Low 
function 
0.50 0.45-0.55   0.58 0.52-0.67 <0.001   0.61 0.55-0.67 0.001        
  
High 
function 
0.60 0.53-0.68 0.003 0.63 0.55-0.70 0.37 0.22 0.66 0.58-0.73 0.062 0.17       
ROM Total 5.7 3.6-6.3   6.4 5.3-7.9 <0.001   7.5 5.5-8.4 0.014   7.3 5.9-8.9 0.12 
(°) 
Low 
function 
4.7 3.2-6.0   6.3 5.0-7.7 <0.001   7.2 6.0-8.4 0.010        
  
High 
function 
6.0 5.3-7.5 0.015 6.4 5.8-8.0 0.10 0.57 7.7 5.0-8.4 0.051 0.97       
Step 
irregularity 
Total 0.05 0.03-0.07   0.05 0.03-0.06 0.65   0.04 0.03-0.06 0.26   0.03 0.02-0.04 0.37 
 (CV) 
Low 
function 
0.05 0.04-0.07   0.04 0.03-0.07 0.40   0.04 0.03-0.06 0.44        
  
High 
function 
0.06 0.03-0.07 0.68 0.05 0.04-0.06 0.60 0.38 0.05 0.03-0.06 0.42 0.55       
Step 
asymmetry 
Total 4.75 1.78-7.82   2.92 1.58-7.05 0.34   2.67 0.88-5.51 0.93   3.28 1.81-5.77 0.87 
 (%) 
Low 
function 
5.97 2.05-8.00   2.20 1.58-4.67 0.28   3.18 0.70-5.23 0.88        
  
High 
function 
3.46 1.58-7.45 0.47 5.99 2.03-7.69 0.71 0.15 2.38 1.34-5.92 0.85 0.66       
Table 1: Outcomes of WOMAC function score and gait parameters for the total patient group and sub groups with a low pre-operative 167 
WOMAC function score (below median) and a high pre-operative WOMAC function score (above median). IQR= interquartile range. 168 
  WOMAC function score 
  pre-operative 3 months 12 months 
  r p-value r p-value r p-value 
Speed 0.51 0.002 0.31 0.071 0.45 0.005 
Cadence 0.31 0.062 0.24 0.158 0.37 0.027 
Step time -0.31 0.062 -0.24 0.158 -0.37 0.027 
Step length 0.47 0.004 0.25 0.134 0.32 0.059 
ROM 0.43 0.010 0.14 0.422 0.51 0.002 
Step time irregularity -0.06 0.717 -0.26 0.119 -0.39 0.018 
Step time asymmetry -0.11 -0.530 0.06 0.741 -0.33 0.047 
Table 2: Spearman correlation coefficients (r) between WOMAC function score and gait parameters with corresponding p-values. 169 
Averaged change per month Pre-operative – 3 months Low vs High  3 months – 12 months Low vs High 
    Mean CI (95%) P-value P-value Mean CI (95%) P-value P-value 
WOMAC function 
score (0-100) 
Total 8.45 6.36 - 10.54 <0.001   0.17 -0.26 - 0.59 0.44   
  Low function 13.31 11.08 - 15.55 <0.001   -0.039 -0.62 - 0.54 0.89   
  High function 3.59 2.10 - 5.08 <0.001 <0.001 0.37 -0.25 - 1.00 0.24 0.34 
Speed 
(m/s) 
Total 0.035 0.016 - 0.055 <0.001   0.008 0.004 - 0.012 <0.001   
  Low function 0.060 0.030 - 0.091 <0.001   0.008 0.003 - 0.013 0.001   
  High function 0.011 -0.009 - 0.030 0.28 0.007 0.008 0 - 0.014 0.28 0.86 
Cadence 
(steps/min) 
Total 1.50 0.39 - 2.60 0.008   0.24 -0.01 - 0.49 0.056   
  Low function 2.64 0.71 - 4.58 0.007   0.35 -0.03 - 0.73 0.069   
  High function 0.35 -0.48 - 1.17 0.41 0.03 0.13 -0.19 - 0.45 0.42 0.39 
Step time 
(s) 
Total -0.010 -0.002 - -0.019 0.02   -0.001 -0.002 - 0 0.11   
  Low function -0.019 -0.035 - -0.003 0.02   -0.001 -0.004 - 0.001 0.19   
  High function -0.002 -0.003 - 0 0.48 0.039 -0.001 -0.003 - 0.001 0.35 0.67 
Step length 
(m) 
Total 0.013 0.006 - 0.02 <0.001   0.003 0.001 - 0.004 <0.001   
  Low function 0.023 0.013 - 0.033 <0.001   0.002 0.001 - 0.004 0.001   
  High function 0.004 -0.005 - 0.014 0.37 0.009 0.003 0.001 - 0.006 0.012 0.57 
ROM 
(°) 
Total 0.31 0.16 - 0.45 <0.001   0.046 0.015 - 0.108 0.014   
  Low function 0.43 0.25 - 0.62 <0.001   0.059 -0.012 - 0.129 0.010   
  High function 0.18 -0.04 - 0.40 0.10 0.08 0.034 0.068 - 0.137 0.051 0.70 
Step irregularity 
log(cv) 
Total -0.015 -0.08 - 0.05 0.65   -0.015 -0.04 - 0.01 0.26   
  Low function -0.049 -0.164 - 0.056 0.40   -0.012 -0.043 - 0.019 0.44   
  High function 0.019 -0.051 - 0.088 0.60 0.32 -0.018 -0.062 - 0.026 0.42 0.82 
Step asymmetry 
log(%) 
Total -0.086 -0.263 - 0.091 0.34   0.003 -0.062 - 0.068 0.93   
  Low function -0.118 -0.334 - 0.098 0.28   -0.005 -0.069 - 0.059 0.88   
  High function -0.055 -0.341 - 0.232 0.85 0.73 0.011 -0.104 - 0.125 0.85 0.81 
Table 3: Averaged change per month during the first 3 post-operative months and the following 9 post-operative months, comparing 170 
the low function group with the high function group. CI=confident interval. 171 
4. Discussion 172 
The primary aim of this study was to compare physical function after THA between patients with a low and 173 
high self-reported level of pre-operative physical function, by subjective self-reported WOMAC function 174 
scores and objective inertial sensor based gait analysis. Although it has been demonstrated that the post-175 
operative outcomes of patients with lower pre-operative WOMAC function scores do not improve to the 176 
same magnitude as patients with higher pre-operative scores [8], it was hypothesized that these differences 177 
in functional outcome may not be found with objective measures of gait. To address this hypothesis, the 178 
study’s cohort was divided into a low and a high function group using the median of the pre-operative 179 
WOMAC function score (i.e. 49) as a cut-off. These self-reported levels of physical function are in 180 
comparison with the findings of previous studies by Unnanuntana et al. [23] and Mahomed et al. [35] which 181 
reported mean pre-operative WOMAC function scores of 48.5 and 46 respectively in their cohorts of pre-182 
operative THA patients. In the current study, patients with lower pre-operative WOMAC function scores 183 
also performed significantly worse on gait pre-operatively; they walked slower, with smaller steps and less 184 
ROM. However, only weak to moderate correlations (Spearman’s r range 0.43-0.51) were found between 185 
pre-operative WOMAC function scores and pre-operative gait parameters. These findings concur with the 186 
results from the study by Unnanuntana et al. [23], which reported a Spearman’s correlation coefficient of 187 
0.54 between pre-operative WOMAC function scores and a 2-minute walk test. Findings from our study and 188 
previous research suggest that WOMAC and gait capture a different dimension of physical function.  189 
Our study’s main finding was that the significant differences in pre-operative WOMAC function scores and 190 
gait parameters between low and high function groups are not found at 3 and 12 months after THA. Patients 191 
with a low pre-operative level of physical function seem to experience more functional limitations in relation 192 
to OA and have more functional improvement to gain from surgery. Post-operatively, they improve 193 
significantly more on both subjective self-reported WOMAC function scores and objective gait parameters, 194 
and reach mean functional outcomes comparable to patients with better pre-operative function. Therefore, 195 
in the analysis of functional recovery after THA, our findings suggest that it is important to differentiate a 196 
cohort into subgroups and look at the relative changes instead of focusing solely on absolute changes. In 197 
addition, our findings on functional recovery after THA are in marked contrast to pain based outcomes, 198 
where a pre-operative score is usually a strong predictor of post-operative outcome [9, 10]. Composite pain 199 
and function scores behave like pain scores in predicting outcome [10] which argues for pain and function 200 
to be measured separately as distinct domains. 201 
 202 
The second aim of this study was to compare the trajectories of post-operative recovery between WOMAC 203 
function scores and gait parameters and it was hypothesized that WOMAC function scores would 204 
demonstrate a larger change in the first 3 months and a smaller change in the following 9 months due to 205 
ceiling effects. A ceiling effect occurs when the test is relatively easy and a substantial proportion of 206 
participants reach either maximum or near-maximum scores [12] and when this proportion is larger than 207 
20% at one occasion during longitudinal follow-up [11]. In this study’s cohort, 18 of 36 patients (50%) 208 
reached near-maximum (≥90) WOMAC function scores at 3 months post-operatively, 23 of 36 patients 209 
(64%) reached near-maximum (≥90) WOMAC function scores at 12 months post-operatively and 10 of 36 210 
patients (28%) reached the maximum score (i.e.100) at 12 months post-operatively. Due to this ceiling 211 
effect, further functional improvement will not be captured by the WOMAC function score and the true extent 212 
of a patient’s functional abilities cannot be determined. In contrast, objective measures of function by gait 213 
analysis demonstrated sensitivity to post-operative improvement beyond 3 months follow-up for three main 214 
gait parameters (i.e. speed, step length and ROM); but no further improvements were found for cadence, 215 
step time, asymmetry and irregularity. Moreover, the observed improvement of gait parameters between 216 
pre-operative status and 3 months after THA, was only found in patients with a low pre-operative function 217 
and between 3 and 12 months after THA only step length demonstrated a significant improvement in the 218 
high function group. For step time irregularity and step time asymmetry, the lack of significant differences 219 
may be due to inaccuracy of the algorithm to measure heel strike events precisely, as literature reports 220 
mean errors of 13ms (SD= 35ms) for heel strike measurements with this specific algorithm compared to 221 
force plate measurements [29]. Furthermore, the small subgroup size (n=18) may lack power for the minor 222 
gait improvements observed in the high function patient group to become statistically significant. Another 223 
explanation for the lack of significant post-operative changes for gait parameters in the high function group 224 
could be that gait is a low demand task in comparison to other activities of daily living, which may be better 225 
discriminators of outcome for those with high pre-operative function. Normal gait is also a main rehabilitation 226 
goal in the early post-operative stage, therefore practiced extensively and thus likely to improve quickly 227 
[32]. Challenging physical tasks may have higher sensitivity as a tool to identify remaining functional 228 
disabilities post-operatively [36]. For gait, variation of walking speed (e.g. preferred speed vs. high speed) 229 
could provide a bigger challenge [37]. Other physically more demanding performance-based tests, such as  230 
timed get-up-and-go (TUG), six minute walk test (6MWT) and stair climbing test (SCT) could be used as 231 
an alternative to the objective functional test described in this study [38, 39].  232 
 233 
The third aim of this study was to compare the outcomes of gait analysis one year after THA from our cohort 234 
with those of a healthy control group without lower limb OA or previous lower limb surgery, and we 235 
hypothesized that gait performance after THA would still be slightly worse than in healthy controls [25]. Our 236 
results demonstrated that by 12 months post-operatively, patients with a THA had nearly reached the level 237 
of the control group in gait performance, except for the parameters speed and step length. At 12 months 238 
after THA, patients seem to walk with a similar step frequency compared to healthy controls but with smaller 239 
steps and consequently lower speed. These findings are in accordance to the results of a meta-analysis by 240 
Ewen et al. [40] including 7 studies comparing gait between patients >6 months after THA and a control 241 
group. Across these studies, the mean walking speed for the patient groups and control groups ranged 242 
from 0.707–1.31 m/s and 0.921–1.34 m/s respectively, and 3 studies reported significantly lower walking 243 
speed for their patient group compared to their control group. Furthermore, 6 studies reported stride length 244 
and 4 of these studies reported a significant reduction in stride length for their patient group compared to 245 
their control group. A more recent systematic review by Kolk et al. [25] describes the results from 28 studies 246 
comparing gait between patients after THA and a control group, including the 7 studies from the meta-247 
analysis by Ewen et al. [40], and demonstrates that walking speed was not different from controls in most 248 
studies that had a short (6-9 months) follow-up period, whereas it was lower than controls in most of the 249 
studies that had a follow-up of 24 months or longer. This coincided with a reduction in step length in the 250 
long-term follow-up studies, which was generally not found in the short-term follow-up studies. In our current 251 
study, the patient group demonstrated a median walking speed of 1.20m/s at 12 months follow-up which 252 
was significantly lower than our control group with a median walking speed of 1.29m/s (p=0.036). 253 
Furthermore, step length was also significantly reduced in our patient population at 12 months follow-up 254 
compared to our control group (0.64m vs. 0.68m; p=0.004). 255 
 256 
Limitations of the study should be acknowledged when interpreting the results. Although the inclusion of 257 
multiple assessment times is a strength, the assessment of function at 3 and 12 months post-operatively 258 
may not capture the full extent of post-operative changes in physical function. As most of the functional 259 
improvement was demonstrated within 3 months post-operatively for WOMAC function scores and for gait 260 
parameters, earlier follow-up measures (e.g. six weeks post-operatively) could provide more insight in 261 
recovery and guide early individual rehabilitation [17]. In order to capture improvement of physical function 262 
beyond 12 months post-operatively and in patients with high pre-operative function, we advocate combining 263 
gait analysis with more high demand tasks. Another limitation of our study is the small sample size and, as 264 
with any prospective cohort study, missing data. Only patients undergoing primary THA were included in 265 
the analysis and patients that did not complete all the assessments were excluded. Consequently, our small 266 
study population limits the conclusions that can be drawn. However, the study was exploratory in nature 267 
and generated findings that can be investigated further.  268 
 269 
5. Conclusion 270 
This study indicates that in a cohort of patients undergoing THA, pre-operative differences in mean WOMAC 271 
function scores and gait parameters between low and high function subgroups have disappeared by 3 272 
months post-operatively. Therefore, it may be important to look at the relative changes rather than the 273 
absolute changes only. Furthermore, assessment of physical function by self-report showed marked 274 
improvement in the first 3 months after surgery with little further improvement thereafter, whereas gait 275 
analysis showed a more gradual improvement over 12 months with sensitivity to capture improvement 276 
beyond 3 months after THA. The weak to moderate correlations between both methods suggest that they 277 
measure slightly different aspects of functional recovery and can be supplementary to each other.  278 
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